Dmytro Shymkiv: in the global economy, pharmaceutical is considered among the most innovative industry - Service
Description of the Service
Due to the company’s top manager’s speech, the Darnytsia Group has taken a leading position in the Ukrainian pharmaceutical industry within the frame of the program to preserve and increase the sales market. Of course, the worldwide Covid-19 pandemic forced the factory's management to search for alternative approaches to solutions in terms of production. In the context of the pandemic, the pharmaceutical concern activated all its reserves in order to provide Ukrainian consumers with affordable medicines of its own production as much as possible.
Accounting for the state of the global pharmaceutical market, Dmytro Shymkiv noted that the drug development and manufacturing industry holds now the crown in the segment of innovations. Such recognized authorities like Moderna, Pfizer, Novavax, Jonson & Jonson, AstraZeneca occupy the top positions in the ranking. These pharmaceutical corporations became leaders because of their capability to develop, test, start mass production and global market of effective Covid-19 vaccines in less than a year. Such success has empowered other pharmaceutical companies to continuously and systematically implement new technologies in drug production.
In turn, the Darnytsia Group set a non-stop innovation process, which allowed it to achieve significant investments in new projects and developments. There are detailed statistical data that are pieces of evidence of the company’s progress. They indicate the leading position of the concern in the domestic pharmaceutical industry in terms of the volume of products sold. Dmytro Shymkiv also emphasized that the traditional distrust of Ukrainians towards local pharmaceutical manufacturers is groundless. To prove his statements, he reported some important official data. Due to them, the Ukrainian drugs produced by the Darnytsia company undergo the final stages of research in the laboratories of the European countries, entirely comply with European requirements, and are successfully put on the EU markets.